Global Gastrointestinal Drugs Market Insights, Forecast to 2029

Global Gastrointestinal Drugs Market Insights, Forecast to 2029

Table of Contents
1 STUDY COVERAGE 1
1.1 Gastrointestinal Drugs Product Introduction 1
1.2 Market by Type 2
1.2.1 Global Gastrointestinal Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 2
1.2.2 Prescription Gastrointestinal Drug 3
1.2.3 OTC Gastrointestinal Drug 4
1.3 Market by Application 5
1.3.1 Global Gastrointestinal Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 5
1.3.2 Inflammatory Bowel Disease 7
1.3.3 IBS Disease 8
1.3.4 Peptic Ulcer 9
1.3.5 GERD 10
1.4 Assumptions and Limitations 10
1.5 Study Objectives 11
1.6 Years Considered 12
2 EXECUTIVE SUMMARY 13
2.1 Global Gastrointestinal Drugs Revenue Estimates and Forecasts 2018-2029 13
2.2 Global Gastrointestinal Drugs Revenue by Region 14
2.2.1 Global Gastrointestinal Drugs Revenue by Region: 2018 VS 2022 VS 2029 14
2.2.2 Global Gastrointestinal Drugs Revenue by Region (2018-2023) 17
2.2.3 Global Gastrointestinal Drugs Revenue by Region (2024-2029) 17
2.2.4 Global Gastrointestinal Drugs Revenue Market Share by Region (2018-2029) 17
2.3 Global Gastrointestinal Drugs Sales Estimates and Forecasts 2018-2029 19
2.4 Global Gastrointestinal Drugs Sales by Region 19
2.4.1 Global Gastrointestinal Drugs Sales by Region: 2018 VS 2022 VS 2029 19
2.4.2 Global Gastrointestinal Drugs Sales by Region (2018-2023) 20
2.4.3 Global Sales Gastrointestinal Drugs by Region (2024-2029) 20
2.4.4 Global Gastrointestinal Drugs Sales Market Share by Region (2018-2029) 21
2.5 North America 22
2.6 Europe 23
2.7 China 24
2.8 Asia (excluding China) 25
2.9 Middle East, Africa and Latin America 26
3 COMPETITION BY MANUFACTURERS 28
3.1 Global Gastrointestinal Drugs Sales by Manufacturers 28
3.1.1 Global Gastrointestinal Drugs Sales by Manufacturers (2018-2023) 28
3.1.2 Global Gastrointestinal Drugs Sales Market Share by Manufacturers (2018-2023) 29
3.1.3 Global Top Largest Manufacturers of Gastrointestinal Drugs in 2022 29
3.2 Global Gastrointestinal Drugs Revenue by Manufacturers 30
3.2.1 Global Gastrointestinal Drugs Revenue by Manufacturers (2018-2023) 30
3.2.2 Global Gastrointestinal Drugs Revenue Market Share by Manufacturers (2018-2023) 31
3.2.3 Global Top Companies by Gastrointestinal Drugs Revenue in 2022 32
3.3 Global Key Players of Gastrointestinal Drugs, Industry Ranking, 2021 VS 2022 33
3.4 Global Gastrointestinal Drugs Sales Price by Manufacturers (2018-2023) 33
3.5 Analysis of Competitive Landscape 34
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 34
3.5.2 Global Gastrointestinal Drugs Market by Company Type (Tier 1, Tier 2, and Tier 3) 35
3.6 Global Key Manufacturers of Gastrointestinal Drugs, Manufacturing Base Distribution and Headquarters 36
3.7 Global Key Manufacturers of Gastrointestinal Drugs, Founded Date 37
3.8 Mergers & Acquisitions, Expansion Plans 37
4 MARKET SIZE BY TYPE 40
4.1 Global Gastrointestinal Drugs Sales by Type 40
4.1.1 Global Gastrointestinal Drugs Historical Sales by Type (2018-2023) 40
4.1.2 Global Gastrointestinal Drugs Forecasted Sales by Type (2024-2029) 40
4.1.3 Global Gastrointestinal Drugs Sales Market Share by Type (2018-2029) 40
4.2 Global Gastrointestinal Drugs Revenue by Type 41
4.2.1 Global Gastrointestinal Drugs Historical Revenue by Type (2018-2023) 41
4.2.2 Global Gastrointestinal Drugs Forecasted Revenue by Type (2024-2029) 42
4.2.3 Global Gastrointestinal Drugs Revenue Market Share by Type (2018-2029) 42
4.3 Global Gastrointestinal Drugs Price by Type 43
4.3.1 Global Gastrointestinal Drugs Price by Type (2018-2023) 43
4.3.2 Global Gastrointestinal Drugs Price Forecast by Type (2024-2029) 43
5 MARKET SIZE BY APPLICATION 44
5.1 Global Gastrointestinal Drugs Sales by Application 44
5.1.1 Global Gastrointestinal Drugs Historical Sales by Application (2018-2023) 44
5.1.2 Global Gastrointestinal Drugs Forecasted Sales by Application (2024-2029) 44
5.1.3 Global Gastrointestinal Drugs Sales Market Share by Application (2018-2029) 45
5.2 Global Gastrointestinal Drugs Revenue by Application 46
5.2.1 Global Gastrointestinal Drugs Historical Revenue by Application (2018-2023) 46
5.2.2 Global Gastrointestinal Drugs Forecasted Revenue by Application (2024-2029) 47
5.2.3 Global Gastrointestinal Drugs Revenue Market Share by Application (2018-2029) 47
5.3 Global Gastrointestinal Drugs Price by Application 49
5.3.1 Global Gastrointestinal Drugs Price by Application (2018-2023) 49
5.3.2 Global Gastrointestinal Drugs Price Forecast by Application (2024-2029) 49
6 NORTH AMERICA 50
6.1 North America Gastrointestinal Drugs Market Size by Type 50
6.1.1 North America Gastrointestinal Drugs Sales by Type (2018-2029) 50
6.1.2 North America Gastrointestinal Drugs Revenue by Type (2018-2029) 51
6.2 North America Gastrointestinal Drugs Market Size by Application 52
6.2.1 North America Gastrointestinal Drugs Sales by Application (2018-2029) 52
6.2.2 North America Gastrointestinal Drugs Revenue by Application (2018-2029) 53
6.3 North America Gastrointestinal Drugs Market Size by Country 55
6.3.1 North America Gastrointestinal Drugs Revenue by Country: 2018 VS 2022 VS 2029 55
6.3.2 North America Gastrointestinal Drugs Revenue by Country (2018-2029) 55
6.3.3 North America Gastrointestinal Drugs Sales by Country (2018-2029) 56
6.3.4 US 57
6.3.5 Canada 58
7 EUROPE 59
7.1 Europe Gastrointestinal Drugs Market Size by Type 59
7.1.1 Europe Gastrointestinal Drugs Sales by Type (2018-2029) 59
7.1.2 Europe Gastrointestinal Drugs Revenue by Type (2018-2029) 60
7.2 Europe Gastrointestinal Drugs Market Size by Application 61
7.2.1 Europe Gastrointestinal Drugs Sales by Application (2018-2029) 61
7.2.2 Europe Gastrointestinal Drugs Revenue by Application (2018-2029) 62
7.3 Europe Gastrointestinal Drugs Market Size by Country 63
7.3.1 Europe Gastrointestinal Drugs Revenue by Country: 2018 VS 2022 VS 2029 63
7.3.2 Europe Gastrointestinal Drugs Revenue by Country (2018-2029) 64
7.3.3 Europe Gastrointestinal Drugs Sales by Country (2018-2029) 65
7.3.4 Germany 66
7.3.5 France 67
7.3.6 UK 67
7.3.7 Italy 68
7.3.8 Russia 68
8 CHINA 69
8.1 China Gastrointestinal Drugs Market Size by Type 69
8.1.1 China Gastrointestinal Drugs Sales by Type (2018-2029) 69
8.1.2 China Gastrointestinal Drugs Revenue by Type (2018-2029) 70
8.2 China Gastrointestinal Drugs Market Size by Application 71
8.2.1 China Gastrointestinal Drugs Sales by Application (2018-2029) 71
8.2.2 China Gastrointestinal Drugs Revenue by Application (2018-2029) 72
9 ASIA (EXCLUDING CHINA) 74
9.1 Asia Gastrointestinal Drugs Market Size by Type 74
9.1.1 Asia Gastrointestinal Drugs Sales by Type (2018-2029) 74
9.1.2 Asia Gastrointestinal Drugs Revenue by Type (2018-2029) 75
9.2 Asia Gastrointestinal Drugs Market Size by Application 76
9.2.1 Asia Gastrointestinal Drugs Sales by Application (2018-2029) 76
9.2.2 Asia Gastrointestinal Drugs Revenue by Application (2018-2029) 77
9.3 Asia Gastrointestinal Drugs Market Size by Region 78
9.3.1 Asia Gastrointestinal Drugs Revenue by Region: 2018 VS 2022 VS 2029 78
9.3.2 Asia Gastrointestinal Drugs Revenue by Region (2018-2029) 79
9.3.3 Asia Gastrointestinal Drugs Sales by Region (2018-2029) 80
9.3.4 Japan 81
9.3.5 South Korea 82
9.3.6 Southeast Asia 82
9.3.7 India 83
9.3.8 Australia 83
10 MIDDLE EAST, AFRICA AND LATIN AMERICA 84
10.1 Middle East, Africa and Latin America Gastrointestinal Drugs Market Size by Type 84
10.1.1 Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Type (2018-2029) 84
10.1.2 Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Type (2018-2029) 84
10.2 Middle East, Africa and Latin America Gastrointestinal Drugs Market Size by Application 85
10.2.1 Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Application (2018-2029) 85
10.2.2 Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Application (2018-2029) 86
10.3 Middle East, Africa and Latin America Gastrointestinal Drugs Market Size by Country 88
10.3.1 Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Country: 2018 VS 2022 VS 2029 88
10.3.2 Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Country (2018-2029) 88
10.3.3 Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Country (2018-2029) 89
10.3.4 Brazil 91
10.3.5 Mexico 91
10.3.6 Middle East 92
10.3.7 Africa 92
11 CORPORATE PROFILE 93
11.1 Takeda 93
11.1.1 Takeda Company Information 93
11.1.2 Takeda Overview 93
11.1.3 Takeda Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023) 94
11.1.4 Takeda Gastrointestinal Drugs Product Descriptions 94
11.1.5 Takeda Recent Developments 95
11.2 AstraZeneca 97
11.2.1 AstraZeneca Company Information 97
11.2.2 AstraZeneca Overview 97
11.2.3 AstraZeneca Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023) 98
11.2.4 AstraZeneca Gastrointestinal Drugs Product Descriptions 98
11.2.5 AstraZeneca Recent Developments 98
11.3 Bayer 99
11.3.1 Bayer Company Information 99
11.3.2 Bayer Overview 100
11.3.3 Bayer Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023) 100
11.3.4 Bayer Gastrointestinal Drugs Product Descriptions 101
11.3.5 Bayer Recent Developments 102
11.4 Pfizer 103
11.4.1 Pfizer Company Information 103
11.4.2 Pfizer Overview 103
11.4.3 Pfizer Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023) 104
11.4.4 Pfizer Gastrointestinal Drugs Product Descriptions 104
11.4.5 Pfizer Recent Developments 104
11.5 Sun Pharma 105
11.5.1 Sun Pharma Company Information 105
11.5.2 Sun Pharma Overview 106
11.5.3 Sun Pharma Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023) 106
11.5.4 Sun Pharma Gastrointestinal Drugs Product Descriptions 107
11.6 Teva 107
11.6.1 Teva Company Information 107
11.6.2 Teva Overview 107
11.6.3 Teva Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023) 108
11.6.4 Teva Gastrointestinal Drugs Product Descriptions 108
11.6.5 Teva Recent Developments 109
11.7 Zeria 110
11.7.1 Zeria Company Information 110
11.7.2 Zeria Overview 110
11.7.3 Zeria Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023) 111
11.7.4 Zeria Gastrointestinal Drugs Product Descriptions 111
11.7.5 Zeria Recent Developments 112
11.8 Perrigo 113
11.8.1 Perrigo Company Information 113
11.8.2 Perrigo Overview 113
11.8.3 Perrigo Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023) 114
11.8.4 Perrigo Gastrointestinal Drugs Product Descriptions 114
11.9 Eisai Co. 115
11.9.1 Eisai Co. Company Information 115
11.9.2 Eisai Co. Overview 116
11.9.3 Eisai Co. Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023) 116
11.9.4 Eisai Co. Gastrointestinal Drugs Product Descriptions 117
11.10 Abbvie 118
11.10.1 Abbvie Company Information 118
11.10.2 Abbvie Overview 118
11.10.3 Abbvie Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023) 119
11.10.4 Abbvie Gastrointestinal Drugs Product Descriptions 119
11.10.5 Abbvie Recent Developments 120
11.11 Jiangzhong 121
11.11.1 Jiangzhong Company Information 121
11.11.2 Jiangzhong Overview 122
11.11.3 Jiangzhong Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023) 123
11.11.4 Jiangzhong Gastrointestinal Drugs Product Descriptions 123
11.12 AOSAIKANG Pharma 124
11.12.1 AOSAIKANG Pharma Company Information 124
11.12.2 AOSAIKANG Pharma Overview 124
11.12.3 AOSAIKANG Pharma Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023) 126
11.12.4 AOSAIKANG Pharma Gastrointestinal Drugs Product Descriptions 126
11.13 Luoxin Pharma 127
11.13.1 Luoxin Pharma Company Information 127
11.13.2 Luoxin Pharma Overview 128
11.13.3 Luoxin Pharma Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023) 128
11.13.4 Luoxin Pharma Gastrointestinal Drugs Product Descriptions 129
11.14 LIVZON 130
11.14.1 LIVZON Company Information 130
11.14.2 LIVZON Overview 130
11.14.3 LIVZON Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023) 132
11.14.4 LIVZON Gastrointestinal Drugs Product Descriptions 133
11.15 Huadong Pharmaceutical 133
11.15.1 Huadong Pharmaceutical Company Information 133
11.15.2 Huadong Pharmaceutical Overview 134
11.15.3 Huadong Pharmaceutical Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023) 135
11.15.4 Huadong Pharmaceutical Gastrointestinal Drugs Product Descriptions 135
11.16 Bausch Health 136
11.16.1 Bausch Health Company Information 136
11.16.2 Bausch Health Overview 137
11.16.3 Bausch Health Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023) 137
11.16.4 Bausch Health Gastrointestinal Drugs Product Descriptions 138
11.16.5 Bausch Health Recent Developments 138
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS 140
12.1 Gastrointestinal Drugs Industry Chain Analysis 140
12.2 Gastrointestinal Drugs Key Raw Materials 140
12.2.1 Key Raw Materials 140
12.2.2 Raw Materials Key Suppliers 141
12.3 Gastrointestinal Drugs Production Mode & Process 142
12.4 Gastrointestinal Drugs Sales and Marketing 143
12.4.1 Gastrointestinal Drugs Sales Channels 144
12.4.2 Gastrointestinal Drugs Distributors 145
12.5 Gastrointestinal Drugs Customers 147
13 GASTROINTESTINAL DRUGS MARKET DYNAMICS 150
13.1.1 Gastrointestinal Drugs Industry Trends 150
13.1.2 Gastrointestinal Drugs Market Drivers 151
13.1.3 Gastrointestinal Drugs Market Challenges 152
13.1.4 Gastrointestinal Drugs Market Restraints 153
14 KEY FINDINGS IN THE GLOBAL GASTROINTESTINAL DRUGS STUDY 154
15 APPENDIX 156
15.1 Research Methodology 156
15.1.1 Methodology/Research Approach 156
15.1.2 Data Source 159
15.2 Author Details 161
15.3 Disclaimer 164
List of Tables
Table 1. Global Gastrointestinal Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million) 2
Table 2. Global Gastrointestinal Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million) 5
Table 3. Global Gastrointestinal Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million) 15
Table 4. Global Gastrointestinal Drugs Revenue by Region (2018-2023) & (US$ Million) 17
Table 5. Global Gastrointestinal Drugs Revenue by Region (2024-2029) & (US$ Million) 17
Table 6. Global Gastrointestinal Drugs Revenue Market Share by Region (2018-2023) 17
Table 7. Global Gastrointestinal Drugs Revenue Market Share by Region (2024-2029) 18
Table 8. Global Gastrointestinal Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (M Units) 19
Table 9. Global Gastrointestinal Drugs Sales by Region (2018-2023) & (M Units) 20
Table 10. Global Gastrointestinal Drugs Sales by Region (2024-2029) & (M Units) 20
Table 11. Global Gastrointestinal Drugs Sales Market Share by Region (2018-2023) 21
Table 12. Global Gastrointestinal Drugs Sales Market Share by Region (2024-2029) 21
Table 13. Global Gastrointestinal Drugs Sales by Manufacturers (2018-2023) & (M Units) 28
Table 14. Global Gastrointestinal Drugs Sales Share by Manufacturers (2018-2023) 29
Table 15. Global Gastrointestinal Drugs Revenue by Manufacturers (2018-2023) & (US$ Million) 30
Table 16. Global Gastrointestinal Drugs Revenue Market Share by Manufacturers (2018-2023) 31
Table 17. Global Key Players of Gastrointestinal Drugs, Industry Ranking, 2021 VS 2022 33
Table 18. Gastrointestinal Drugs Price by Manufacturers (2018-2023) & (USD/Unit) 33
Table 19. Global Gastrointestinal Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) 35
Table 20. Global Gastrointestinal Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Drugs as of 2022) 35
Table 21. Global Key Manufacturers of Gastrointestinal Drugs, Manufacturing Base Distribution and Headquarters 36
Table 22. Global Key Manufacturers of Gastrointestinal Drugs, Founded Date 37
Table 23. Mergers & Acquisitions, Expansion Plans 37
Table 24. Global Gastrointestinal Drugs Sales by Type (2018-2023) & (M Units) 40
Table 25. Global Gastrointestinal Drugs Sales by Type (2024-2029) & (M Units) 40
Table 26. Global Gastrointestinal Drugs Sales Share by Type (2018-2023) 40
Table 27. Global Gastrointestinal Drugs Sales Share by Type (2024-2029) 41
Table 28. Global Gastrointestinal Drugs Revenue by Type (2018-2023) & (US$ Million) 41
Table 29. Global Gastrointestinal Drugs Revenue by Type (2024-2029) & (US$ Million) 42
Table 30. Global Gastrointestinal Drugs Revenue Share by Type (2018-2023) 42
Table 31. Global Gastrointestinal Drugs Revenue Share by Type (2024-2029) 42
Table 32. Gastrointestinal Drugs Price by Type (2018-2023) & (USD/Unit) 43
Table 33. Global Gastrointestinal Drugs Price Forecast by Type (2024-2029) & (USD/Unit) 43
Table 34. Global Gastrointestinal Drugs Sales by Application (2018-2023) & (M Units) 44
Table 35. Global Gastrointestinal Drugs Sales by Application (2024-2029) & (M Units) 44
Table 36. Global Gastrointestinal Drugs Sales Share by Application (2018-2023) 45
Table 37. Global Gastrointestinal Drugs Sales Share by Application (2024-2029) 45
Table 38. Global Gastrointestinal Drugs Revenue by Application (2018-2023) & (US$ Million) 46
Table 39. Global Gastrointestinal Drugs Revenue by Application (2024-2029) & (US$ Million) 47
Table 40. Global Gastrointestinal Drugs Revenue Share by Application (2018-2023) 47
Table 41. Global Gastrointestinal Drugs Revenue Share by Application (2024-2029) 48
Table 42. Gastrointestinal Drugs Price by Application (2018-2023) & (USD/Unit) 49
Table 43. Global Gastrointestinal Drugs Price Forecast by Application (2024-2029) & (USD/Unit) 49
Table 44. North America Gastrointestinal Drugs Sales by Type (2018-2023) & (M Units) 50
Table 45. North America Gastrointestinal Drugs Sales by Type (2024-2029) & (M Units) 50
Table 46. North America Gastrointestinal Drugs Revenue by Type (2018-2023) & (US$ Million) 51
Table 47. North America Gastrointestinal Drugs Revenue by Type (2024-2029) & (US$ Million) 51
Table 48. North America Gastrointestinal Drugs Sales by Application (2018-2023) & (M Units) 52
Table 49. North America Gastrointestinal Drugs Sales by Application (2024-2029) & (M Units) 52
Table 50. North America Gastrointestinal Drugs Revenue by Application (2018-2023) & (US$ Million) 53
Table 51. North America Gastrointestinal Drugs Revenue by Application (2024-2029) & (US$ Million) 54
Table 52. North America Gastrointestinal Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million) 55
Table 53. North America Gastrointestinal Drugs Revenue by Country (2018-2023) & (US$ Million) 55
Table 54. North America Gastrointestinal Drugs Revenue by Country (2024-2029) & (US$ Million) 55
Table 55. North America Gastrointestinal Drugs Sales by Country (2018-2023) & (M Units) 56
Table 56. North America Gastrointestinal Drugs Sales by Country (2024-2029) & (M Units) 56
Table 57. Europe Gastrointestinal Drugs Sales by Type (2018-2023) & (M Units) 59
Table 58. Europe Gastrointestinal Drugs Sales by Type (2024-2029) & (M Units) 59
Table 59. Europe Gastrointestinal Drugs Revenue by Type (2018-2023) & (US$ Million) 60
Table 60. Europe Gastrointestinal Drugs Revenue by Type (2024-2029) & (US$ Million) 60
Table 61. Europe Gastrointestinal Drugs Sales by Application (2018-2023) & (M Units) 61
Table 62. Europe Gastrointestinal Drugs Sales by Application (2024-2029) & (M Units) 61
Table 63. Europe Gastrointestinal Drugs Revenue by Application (2018-2023) & (US$ Million) 62
Table 64. Europe Gastrointestinal Drugs Revenue by Application (2024-2029) & (US$ Million) 62
Table 65. Europe Gastrointestinal Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million) 63
Table 66. Europe Gastrointestinal Drugs Revenue by Country (2018-2023) & (US$ Million) 64
Table 67. Europe Gastrointestinal Drugs Revenue by Country (2024-2029) & (US$ Million) 64
Table 68. Europe Gastrointestinal Drugs Sales by Country (2018-2023) & (M Units) 65
Table 69. Europe Gastrointestinal Drugs Sales by Country (2024-2029) & (M Units) 65
Table 70. China Gastrointestinal Drugs Sales by Type (2018-2023) & (M Units) 69
Table 71. China Gastrointestinal Drugs Sales by Type (2024-2029) & (M Units) 69
Table 72. China Gastrointestinal Drugs Revenue by Type (2018-2023) & (US$ Million) 70
Table 73. China Gastrointestinal Drugs Revenue by Type (2024-2029) & (US$ Million) 70
Table 74. China Gastrointestinal Drugs Sales by Application (2018-2023) & (M Units) 71
Table 75. China Gastrointestinal Drugs Sales by Application (2024-2029) & (M Units) 71
Table 76. China Gastrointestinal Drugs Revenue by Application (2018-2023) & (US$ Million) 72
Table 77. China Gastrointestinal Drugs Revenue by Application (2024-2029) & (US$ Million) 72
Table 78. Asia Gastrointestinal Drugs Sales by Type (2018-2023) & (M Units) 74
Table 79. Asia Gastrointestinal Drugs Sales by Type (2024-2029) & (M Units) 74
Table 80. Asia Gastrointestinal Drugs Revenue by Type (2018-2023) & (US$ Million) 75
Table 81. Asia Gastrointestinal Drugs Revenue by Type (2024-2029) & (US$ Million) 75
Table 82. Asia Gastrointestinal Drugs Sales by Application (2018-2023) & (M Units) 76
Table 83. Asia Gastrointestinal Drugs Sales by Application (2024-2029) & (M Units) 76
Table 84. Asia Gastrointestinal Drugs Revenue by Application (2018-2023) & (US$ Million) 77
Table 85. Asia Gastrointestinal Drugs Revenue by Application (2024-2029) & (US$ Million) 77
Table 86. Asia Gastrointestinal Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million) 78
Table 87. Asia Gastrointestinal Drugs Revenue by Region (2018-2023) & (US$ Million) 79
Table 88. Asia Gastrointestinal Drugs Revenue by Region (2024-2029) & (US$ Million) 79
Table 89. Asia Gastrointestinal Drugs Sales by Region (2018-2023) & (M Units) 80
Table 90. Asia Gastrointestinal Drugs Sales by Region (2024-2029) & (M Units) 80
Table 91. Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Type (2018-2023) & (M Units) 84
Table 92. Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Type (2024-2029) & (M Units) 84
Table 93. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Type (2018-2023) & (US$ Million) 84
Table 94. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Type (2024-2029) & (US$ Million) 85
Table 95. Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Application (2018-2023) & (M Units) 85
Table 96. Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Application (2024-2029) & (M Units) 85
Table 97. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Application (2018-2023) & (US$ Million) 86
Table 98. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Application (2024-2029) & (US$ Million) 87
Table 99. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million) 88
Table 100. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Country (2018-2023) & (US$ Million) 88
Table 101. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Country (2024-2029) & (US$ Million) 89
Table 102. Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Country (2018-2023) & (M Units) 89
Table 103. Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Country (2024-2029) & (M Units) 90
Table 104. Takeda Company Information 93
Table 105. Takeda Description and Major Businesses 93
Table 106. Takeda Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) 94
Table 107. Takeda Gastrointestinal Drugs Product Descriptions 94
Table 108. Takeda Recent Developments 95
Table 109. AstraZeneca Company Information 97
Table 110. AstraZeneca Description and Major Businesses 97
Table 111. AstraZeneca Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) 98
Table 112. AstraZeneca Gastrointestinal Drugs Product Descriptions 98
Table 113. AstraZeneca Recent Developments 98
Table 114. Bayer Company Information 99
Table 115. Bayer Description and Major Businesses 100
Table 116. Bayer Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) 100
Table 117. Bayer Gastrointestinal Drugs Product Descriptions 101
Table 118. Bayer Recent Developments 102
Table 119. Pfizer Company Information 103
Table 120. Pfizer Description and Major Businesses 103
Table 121. Pfizer Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) 104
Table 122. Pfizer Gastrointestinal Drugs Product Descriptions 104
Table 123. Pfizer Recent Developments 104
Table 124. Sun Pharma Company Information 105
Table 125. Sun Pharma Description and Major Businesses 106
Table 126. Sun Pharma Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) 106
Table 127. Sun Pharma Gastrointestinal Drugs Product Descriptions 107
Table 128. Teva Company Information 107
Table 129. Teva Description and Major Businesses 107
Table 130. Teva Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) 108
Table 131. Teva Gastrointestinal Drugs Product Descriptions 108
Table 132. Teva Recent Developments 109
Table 133. Zeria Company Information 110
Table 134. Zeria Description and Major Businesses 110
Table 135. Zeria Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) 111
Table 136. Zeria Gastrointestinal Drugs Product Descriptions 111
Table 137. Zeria Recent Developments 112
Table 138. Perrigo Company Information 113
Table 139. Perrigo Description and Major Businesses 113
Table 140. Perrigo Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) 114
Table 141. Perrigo Gastrointestinal Drugs Product Descriptions 114
Table 142. Eisai Co. Company Information 115
Table 143. Eisai Co. Description and Major Businesses 116
Table 144. Eisai Co. Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) 116
Table 145. Eisai Co. Gastrointestinal Drugs Product Descriptions 117
Table 146. Abbvie Company Information 118
Table 147. Abbvie Description and Major Businesses 118
Table 148. Abbvie Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) 119
Table 149. Abbvie Gastrointestinal Drugs Product Descriptions 119
Table 150. Abbvie Recent Developments 120
Table 151. Jiangzhong Company Information 121
Table 152. Jiangzhong Description and Major Businesses 122
Table 153. Jiangzhong Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) 123
Table 154. Jiangzhong Gastrointestinal Drugs Product Descriptions 123
Table 155. AOSAIKANG Pharma Company Information 124
Table 156. AOSAIKANG Pharma Description and Major Businesses 124
Table 157. AOSAIKANG Pharma Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) 126
Table 158. AOSAIKANG Pharma Gastrointestinal Drugs Product Descriptions 126
Table 159. Luoxin Pharma Company Information 127
Table 160. Luoxin Pharma Description and Major Businesses 128
Table 161. Luoxin Pharma Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) 128
Table 162. Luoxin Pharma Gastrointestinal Drugs Product Descriptions 129
Table 163. LIVZON Company Information 130
Table 164. LIVZON Description and Major Businesses 130
Table 165. LIVZON Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) 132
Table 166. LIVZON Gastrointestinal Drugs Product Descriptions 133
Table 167. Huadong Pharmaceutical Company Information 133
Table 168. Huadong Pharmaceutical Description and Major Businesses 134
Table 169. Huadong Pharmaceutical Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) 135
Table 170. Huadong Pharmaceutical Gastrointestinal Drugs Product Descriptions 135
Table 171. Bausch Health Company Information 136
Table 172. Bausch Health Description and Major Businesses 137
Table 173. Bausch Health Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) 137
Table 174. Bausch Health Gastrointestinal Drugs Product Descriptions 138
Table 175. Bausch Health Recent Developments 138
Table 176. Key Raw Materials Lists 140
Table 177. Raw Materials Key Suppliers Lists 141
Table 178. Gastrointestinal Drugs Distributors List 145
Table 179. Gastrointestinal Drugs Customers List 147
Table 180. Gastrointestinal Drugs Market Trends 150
Table 181. Gastrointestinal Drugs Market Drivers 151
Table 182. Gastrointestinal Drugs Market Challenges 152
Table 183. Gastrointestinal Drugs Market Restraints 153
Table 184. Research Programs/Design for This Report 156
Table 185. Key Data Information from Secondary Sources 159
Table 186. Key Data Information from Primary Sources 160
Table 187. QYR Business Unit and Senior & Team Lead Analysts 162
List of Figures
Figure 1. Gastrointestinal Drugs Product Picture 1
Figure 2. Global Gastrointestinal Drugs Market Size Growth Rate by Type, 2018-2029 (US$ Million) 2
Figure 3. Global Gastrointestinal Drugs Market Share by Type: 2022 3
Figure 4. Global Gastrointestinal Drugs Market Share by Type: 2029 3
Figure 5. Prescription Gastrointestinal Drug Product Picture 4
Figure 6. OTC Gastrointestinal Drug Product Picture 4
Figure 7. Global Gastrointestinal Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million) 5
Figure 8. Global Gastrointestinal Drugs Market Share by Application: 2022 6
Figure 9. Global Gastrointestinal Drugs Market Share by Application: 2029 7
Figure 10. Inflammatory Bowel Disease 8
Figure 11. IBS Disease 9
Figure 12. Peptic Ulcer 9
Figure 13. GERD 10
Figure 14. Gastrointestinal Drugs Report Years Considered 12
Figure 15. Global Gastrointestinal Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029 13
Figure 16. Global Gastrointestinal Drugs Revenue 2018-2029 (US$ Million) 14
Figure 17. Global Gastrointestinal Drugs Revenue (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million) 15
Figure 18. Global Gastrointestinal Drugs Revenue Market Share by Region in Percentage: 2022 16
Figure 19. Global Gastrointestinal Drugs Revenue Market Share by Region in Percentage: 2029 16
Figure 20. Global Gastrointestinal Drugs Revenue Market Share by Region (2018-2029) 18
Figure 21. Global Gastrointestinal Drugs Sales 2018-2029 (M Units) 19
Figure 22. Global Gastrointestinal Drugs Sales (CAGR) by Region: 2018 VS 2022 VS 2029 (M Units) 20
Figure 23. Global Gastrointestinal Drugs Sales Market Share by Region (2018-2029) 22
Figure 24. North America Gastrointestinal Drugs Sales YoY (2018-2029) & (M Units) 22
Figure 25. North America Gastrointestinal Drugs Revenue YoY (2018-2029) & (US$ Million) 23
Figure 26. Europe Gastrointestinal Drugs Sales YoY (2018-2029) & (M Units) 23
Figure 27. Europe Gastrointestinal Drugs Revenue YoY (2018-2029) & (US$ Million) 24
Figure 28. China Gastrointestinal Drugs Sales YoY (2018-2029) & (M Units) 24
Figure 29. China Gastrointestinal Drugs Revenue YoY (2018-2029) & (US$ Million) 25
Figure 30. Asia (excluding China) Gastrointestinal Drugs Sales YoY (2018-2029) & (M Units) 25
Figure 31. Asia (excluding China) Gastrointestinal Drugs Revenue YoY (2018-2029) & (US$ Million) 26
Figure 32. Middle East, Africa and Latin America Gastrointestinal Drugs Sales YoY (2018-2029) & (M Units) 26
Figure 33. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue YoY (2018-2029) & (US$ Million) 27
Figure 34. The Gastrointestinal Drugs Market Share of Top Largest Manufacturers Around the World in 2022 30
Figure 35. The Top Largest Manufacturers of Gastrointestinal Drugs in the World: Market Share by Gastrointestinal Drugs Revenue in 2022 32
Figure 36. Global Gastrointestinal Drugs Sales Market Share by Type (2018-2029) 41
Figure 37. Global Gastrointestinal Drugs Revenue Market Share by Type (2018-2029) 43
Figure 38. Global Gastrointestinal Drugs Sales Market Share by Application (2018-2029) 46
Fi

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Anti-Peptic Ulcer Drugs Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110

According to our LPI (LP Information) latest study, the global Anti-Peptic Ulcer Drugs market size was valued at US$ 8523.5 million in 2023. With growing demand in downstream market, the Anti-Peptic Ulcer Drugs is forecast to a readjusted size of US$ 21200 million by 2030 with a CAGR of 13.9% during review period. The research report highlights the growth potential of the global Anti-Peptic Ulcer Drugs market. Anti-Peptic Ulcer Drugs are expected to show stable growth in the future marke......

Global Lansoprazole Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 102

The Lansoprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lansoprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......

Global Irritable Bowel Syndrome (IBS) Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88

According to our LPI (LP Information) latest study, the global Irritable Bowel Syndrome (IBS) market size was valued at US$ 4634.2 million in 2023. With growing demand in downstream market, the Irritable Bowel Syndrome (IBS) is forecast to a readjusted size of US$ 12750 million by 2030 with a CAGR of 15.6% during review period. The research report highlights the growth potential of the global Irritable Bowel Syndrome (IBS) market. Irritable Bowel Syndrome (IBS) are expected to show stabl......

Global Esomeprazole Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 89

The Esomeprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Esomeprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......

Global Irritable Bowel Syndrome (IBS) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 126

Market Overview of Global Irritable Bowel Syndrome (IBS) market: According to our latest research, the global Irritable Bowel Syndrome (IBS) market looks promising in the next 5 years. As of 2022, the global Irritable Bowel Syndrome (IBS) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive anal......

Global Diarrhea Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 109

Market Overview of Global Diarrhea Drug market: According to our latest research, the global Diarrhea Drug market looks promising in the next 5 years. As of 2022, the global Diarrhea Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Diarrhea Drug market, with a sys......

Drugs for Traveler's Diarrhea - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 96

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Drugs for Traveler's Diarrhea, with bo......

Global Lansoprazole Professional Survey Report 2023, Forecast to 2028

Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 136

Lansoprazole reduces the amount of acid your stomach makes. It's used for indigestion, heartburn and acid reflux and gastroesophageal-reflux-disease (GORD). Lansoprazole is also taken to prevent and treat stomach ulcers. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their g......

Global Pentasa (Ulcerative Colitis) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 113

Market Overview of Global Pentasa (Ulcerative Colitis) market: According to our latest research, the global Pentasa (Ulcerative Colitis) market looks promising in the next 5 years. As of 2022, the global Pentasa (Ulcerative Colitis) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis o......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs